![Gary Jacob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 186 798 $ al 31/05/2026
Gary S.
Jacob is the founder.
Dr. Jacob is also the founder of Synergy Pharmaceuticals LLC.
Founding positions included Chairman, President & Chief Executive Officer at Synergy Pharmaceuticals, Inc. (2008-2017).
Current jobs include Chief Executive Officer & Executive Director at OKYO Pharma Ltd. (2021-present) and Independent Director at Actavia Life Sciences, Inc. (2020-present).
Former jobs include President, Chief Executive Officer & Director at Callisto Pharmaceuticals, Inc. (2004-2013), President, Chief Executive Officer & Director at Pawfect Foods, Inc. (2008), CEO, Non-Executive Director & Managing Director at Immuron Ltd. (2019-2020), Chairman at Hepion Pharmaceuticals, Inc. (2014-2024), Chairman at Synergy DE (2008), Director-Functional Genomics, Science & Technology at Monsanto Co. (1997-1998), Independent Director at Cardiff Oncology, Inc. (2012-2021), Glycobiology Director at G.D.
Searle LLC (1990-1997), Independent Director at Virpax Pharmaceuticals, Inc. (2020-2022), and Manager-Searle Glycobiology Group at the University of Oxford (1990).
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Missouri-St. Louis.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,21 % | 18/03/2026 | 108.920 ( 0,21 % ) | 186 798 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Director/Miembro de la Junta | 23/12/2020 |
| WEST AFRICAN MINERALS CORP | Director/Miembro de la Junta | 07/01/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director Ejecutivo | 19/03/2014 |
| VIRPAX PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 25/07/2022 |
| IMMURON LIMITED | Director Ejecutivo | 25/03/2020 |
| SYNERGY PHARMACEUTICALS INC | Director Ejecutivo | 19/12/2017 |
Synergy Pharmaceuticals, Inc. /Old/
 Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Director Ejecutivo | 01/10/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Synergy Pharmaceuticals, Inc. /Old/
Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuron Ltd.
 Immuron Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
G.D. Searle LLC | |
Synergy DE | |
University of Missouri-St. Louis
 University of Missouri-St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Virpax Pharmaceuticals, Inc.
 Virpax Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that develops non-addictive pain and neurological disorders | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
